{
  "id": "map_1687",
  "title": "üìö ESTUDIOS PIVOTALES\\N\\NBiblioteca de Evidencia Cl√≠nica\\NCristian Acevedo H., MD\\NResidencia Geriatr√≠a USS\\N\\n40+ estudios indexados\\n√öltima actualizaci√≥n: Enero 2026",
  "specialty": "Estudios Pivotales",
  "tag": "‚≠ê Estudio Pivotal",
  "node_count": 14,
  "root": {
    "text": "üìö ESTUDIOS PIVOTALES\\N\\NBiblioteca de Evidencia Cl√≠nica\\NCristian Acevedo H., MD\\NResidencia Geriatr√≠a USS\\N\\n40+ estudios indexados\\n√öltima actualizaci√≥n: Enero 2026",
    "children": [
      {
        "text": "üë¥ GERIATRIA (20 mapas)\\N\\nHTA Ancianos:\\n‚Üí HYVET, SHEP, Syst-Eur\\n\\nFragilidad:\\n‚Üí Fried Phenotype, ICE-FRAIL\\n‚Üí VIP1/VIP2 (UCI)\\n\\nDelirium:\\n‚Üí HELP, MENDS, MIND-USA\\n‚Üí CATIE-AD, ABCDEF Bundle\\n\\nCognici√≥n:\\n‚Üí FINGER, ASPREE\\n\\nCa√≠das/Funci√≥n:\\n‚Üí STRIDE, LIFE-Study\\n\\nPolifarmacia:\\n‚Üí STOPP-START, OPERAM\\n\\nAnticoagulaci√≥n:\\n‚Üí BAFTA, ELDERCARE-AF\\n\\nOrtogeriatr√≠a:\\n‚Üí FOCUS (transfusi√≥n)\\n\\n[Carpeta: Geriatr√≠a/]",
        "children": [
          {
            "text": "HTA Ancianos:\\n‚Ä¢ HYVET: PAS menor 150 mayor 80\\n‚Ä¢ SHEP: tiazida reduce ACV 36%\\n‚Ä¢ Syst-Eur: BCC efectivo",
            "children": []
          },
          {
            "text": "Fragilidad/UCI:\\n‚Ä¢ Fried: 5 criterios fenotipo\\n‚Ä¢ VIP1/2: CFS predice UCI\\n‚Ä¢ ICE-FRAIL: CFS mayor APACHE",
            "children": []
          },
          {
            "text": "Delirium:\\n‚Ä¢ HELP: previene 40%\\n‚Ä¢ MENDS: Dex mejor que BZD\\n‚Ä¢ MIND-USA: antipsic NO sirven\\n‚Ä¢ ABCDEF: Bundle integral",
            "children": []
          },
          {
            "text": "Cognici√≥n:\\n‚Ä¢ FINGER: multidominio previene\\n‚Ä¢ CATIE-AD: antipsic NO eficaces\\n‚Ä¢ ASPREE: AAS da√±a en sanos",
            "children": []
          },
          {
            "text": "Polifarmacia:\\n‚Ä¢ STOPP-START: criterios\\n‚Ä¢ OPERAM: reduce RAM hosp\\n‚Ä¢ BAFTA: Warf mayor AAS en FA\\n‚Ä¢ ELDERCARE: Edox 15mg muy anc",
            "children": []
          }
        ]
      },
      {
        "text": "‚ù§Ô∏è CARDIOLOGIA (5)\\N\\n‚Üí PARADIGM-HF (Sacubitril IC)\\n‚Üí DAPA-HF (Dapa IC)\\n‚Üí SPRINT (PA menor 120)\\n‚Üí AFFIRM (FA frec vs ritmo)\\n‚Üí SELECT (Sema CV sin DM)\\n\\n[Carpetas: Cardiolog√≠a/ + Endocrinolog√≠a/]",
        "children": []
      },
      {
        "text": "üè• UCI / CRITICOS (5)\\N\\n‚Üí ARDSNet (Vt bajo SDRA)\\n‚Üí PROSEVA (Prono SDRA)\\n‚Üí RECOVERY (Dexa COVID-19)\\n‚Üí CRASH-2 (ATX trauma)\\n‚Üí TRICC (Transfusi√≥n restrictiva)\\n\\n[Carpeta: UCI/]",
        "children": []
      },
      {
        "text": "ü´ò NEFROLOGIA (2)\\N\\n‚Üí CREDENCE (Cana ERC-DM)\\n‚Üí DAPA-CKD (Dapa ERC +/- DM)\\n\\n[Carpeta: Nefrolog√≠a/]",
        "children": []
      },
      {
        "text": "ü¶¥ ORTOGERIATRIA (2)\\N\\n‚Üí HORIZON-RFT (Zol post-Fx)\\n‚Üí FOCUS (Transfusi√≥n cadera)\\n\\n[Carpeta: Ortogeriatr√≠a/]",
        "children": []
      },
      {
        "text": "üß† NEUROLOGIA (1)\\N\\n‚Üí CLARITY-AD (Lecanemab EA)\\n\\n[Carpeta: Neurolog√≠a/]",
        "children": []
      },
      {
        "text": "üïäÔ∏è PALIATIVOS (1)\\N\\n‚Üí Temel 2010 (CP tempranos)\\n\\n[Carpeta: Paliativos/]",
        "children": []
      },
      {
        "text": "üìã ESTRUCTURA MAPAS\\N\\nCada estudio incluye:\\n‚Ä¢ üìã Identificaci√≥n\\n‚Ä¢ üë• Poblaci√≥n\\n‚Ä¢ üíä Intervenci√≥n\\n‚Ä¢ üìä Resultados\\n‚Ä¢ ‚ö†Ô∏è Seguridad\\n‚Ä¢ ‚öñÔ∏è Sesgos\\n‚Ä¢ üë¥ Aplicabilidad Geri√°trica\\n‚Ä¢ üíé Perlas Cl√≠nicas\\n‚Ä¢ üìö Referencias",
        "children": []
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1640",
      "title": "Aciclovir (ACV) versus Valaciclovir (VACV)"
    },
    {
      "id": "map_1668",
      "title": "HORIZON-RFT (2007)\\NHealth Outcomes and Reduced\\NIncidence with Zoledronic Acid\\NOnce Yearly - Recurrent Fracture Trial\\N\\N‚≠ê Zoledronato post fractura cadera\\Nreduce refracturas Y mortalidad"
    },
    {
      "id": "map_1671",
      "title": "ICE-FRAIL (2024)\\N\\n‚≠ê Fragilidad predice mortalidad UCI\\N\\nCFS mejor que APACHE/SOFA solos"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    }
  ],
  "source_file": "00_INDICE_ESTUDIOS_PIVOTALES-2026.smmx",
  "created": "2026-02-07T15:42:53.321567"
}